BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-248

  1. 800 Posts.
    lightbulb Created with Sketch. 383
    You're right.

    It's a double-blinded study.

    I.e. clinic and handlers don't know the batches.

    It seems insane they got it wrong, but looking at the data it's VERY similar if you just swap it around. That would make the most sense at this point.


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.